Integer Holdings Corporation (ITGR)
NYSE: ITGR · Electromedical & Electrotherapeutic Apparatus · Plano, TX
Our rating: Neutral
Neutral reaffirmed at $126.59, moderate conviction, October 30, 2026.
Breaks if: The Neutral call turns Positive if two consecutive quarterly filings show revenue growth of 12% or more alongside net margin expanding above 7%. It turns Cautious if revenue growth slips below 5% or net margin compresses below 4% in any two quarterly prints within the next twelve months.
Key figures
| Market value | $4.3B |
|---|---|
| Revenue, last 12 months | $1.8B |
| Net income, last 12 months | $104M |
| Free cash flow, last 12 months | $82M |
| Price to earnings | 41.6× |
| Free cash flow yield | 1.9% |
| Dividend yield | 0.0% |
| Operating margin | 8.2% |
| Return on equity | 6.0% |
| Beta to the S&P 500 | 0.71 |
| Volatility, annualized | 35.7% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| October 2, 2026 | $450M | −3.9% | $0.43 | $16M |
| July 3, 2026 | $464M | −2.6% | $0.69 | $37M |
| April 3, 2026 | $440M | 0.5% | $0.48 | $737000.00 |
| December 31, 2025 | $472M | 5.0% | $1.37 | $28M |
| September 26, 2025 | $468M | 8.4% | $1.11 | $46M |
| June 27, 2025 | $476M | 11.4% | $1.04 | $25M |
| March 28, 2025 | $437M | 7.3% | $-0.66 | $6M |
| December 31, 2024 | $449M | 11.1% | $0.90 | $44M |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $0.47B: Claude 35%, Gemini 25%, Mistral 45%
- Diluted earnings per share are at least $1.37: Claude 25%, Gemini 15%, Mistral 15%
- Free cash flow for the quarter is at least $0.03B: Claude 45%, Gemini 55%, Mistral 50%
11 ledger entries and 76 corporate events on record. Share price as of November 16, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.